Dr. Shireesha Dhanireddy, MD

Dr. Dhanireddy practices at Harborview Medical Center in Seattle, Washington, part of University of Washington.

Dr. Dhanireddy's NPI, 1568577286, was assigned on August 21, 2006. Dr. Dhanireddy graduated from Georgetown University School of Medicine in 1999. Dr. Dhanireddy holds Washington license MD00040132.

Dr. Dhanireddy's primary practice is Harborview Medical Center, at 325 9th Avenue, Seattle, WA 98104 in King County. The practice phone is (206) 744-9535.

Dr. Dhanireddy's primary practice is Harborview Medical Center in Seattle, Washington, part of University of Washington. The medical group on file is UW Physicians. Dmand AI also links Dr. Dhanireddy to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dhanireddy practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Dhanireddy's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Dhanireddy is licensed in Washington.

CMS data shows 113 Medicare services from Dr. Dhanireddy across 6 procedure codes in 2024, for 82 Medicare patients. Medicare paid $8,748 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 82 Medicare patients who saw Dr. Dhanireddy in 2024. The largest group is 65 to 74, with 33 patients. 66% of them have high blood pressure, and 50% have high cholesterol. 55% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dhanireddy's median patient age at 48, with 27% women.

In 2024, Dr. Dhanireddy wrote 1,116 Medicare Part D claims for 88 patients. 64% of them were for generic drugs. CMS names the drug for 877 of them, across 39 drugs with 11 or more claims each, at $705,084 in total drug cost. In 2023, CMS named 732 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Dhanireddy for performance year 2024, reported through an alternative payment model (APM). Dr. Dhanireddy accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 66 papers to Dr. Dhanireddy, published from 2011 to 2025. 2021 was the busiest year, with 6. The most frequent topics are HIV Infections, Anti-HIV Agents and Sexual Behavior. Dr. Dhanireddy has published most often in Open Forum Infect Dis. Dr. Dhanireddy's most frequent co-authors are Robert D. Harrington, Julia Cook Dombrowski, MD and Matthew Robert Golden, MD.

Dmand AI links Dr. Dhanireddy to 2 clinical trials. Conditions studied include Acquired Immunodeficiency Syndrome, Squamous Intraepithelial Lesions and Morphological and Microscopic Findings.

Dr. Dhanireddy graduated from Georgetown University School of Medicine in 1999.